Has Letarsha Campbell received payments from drug or device companies?

Yes. Drug and device makers reported $5,081 in general payments to Letarsha Campbell across 215 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Letarsha Campbell did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Letarsha Campbell come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Letarsha Campbell

Psychiatric/Mental Health · Clinton, LANPI 1205124310

Payments from drug & device makers

$5,081in general payments, 2019–2025

Across 215 payments — averaging $23.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
AbbVie$956
Neurocrine Biosciences, Inc.$631
Johnson & Johnson$616
Corium, LLC$294
Otsuka America Pharmaceutical, Inc.$283
plus $1K from 12 others

What the payments were for

Food & beverage$5,069100%
Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	60	$1,152
AbbVie	37	$956
Neurocrine Biosciences, Inc.	22	$631
Johnson & Johnson	21	$616
Corium, LLC	8	$294
Otsuka America Pharmaceutical, Inc.	14	$283
Axsome Therapeutics, Inc.	9	$250
Vanda Pharmaceuticals Inc.	6	$165
Alkermes, Inc.	6	$140
Supernus Pharmaceuticals, Inc.	7	$135
Teva Pharmaceuticals USA, Inc.	5	$118
Lundbeck LLC	5	$92
Takeda Pharmaceuticals U.S.A., Inc.	4	$63
Ironshore Pharmaceuticals Inc.	3	$53
E.r. Squibb & Sons, L.L.C.	2	$36
Indivior Inc.	2	$34
Collegium Pharmaceutical, Inc.	2	$33
Tris Pharma Inc	2	$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,081 in reported general payments places this provider in the 85th percentile of 615 psychiatric/mental health providers in Louisiana.

See all psychiatric/mental health providers in Louisiana →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VraylarCariprazine Hcl	17	$23,935
ProzacFluoxetine Hcl	11	$4,960
Paliperidone ErPaliperidone	12	$1,275
Hydroxyzine Hcl	38	$410
Buspirone Hcl	58	$397
Trazodone Hcl	42	$380
Haloperidol	12	$359
Quetiapine Fumarate	28	$356
Olanzapine	36	$338
Aripiprazole	16	$279
Bupropion XlBupropion Hcl	19	$201
Escitalopram Oxalate	23	$197
Venlafaxine Hcl ErVenlafaxine Hcl	18	$179
Donepezil Hcl	11	$105
Sertraline Hcl	16	$55

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieVraylar	$956	$23,93517 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 615 psychiatric/mental health providers in Louisiana.

Other psychiatric/mental health in Clinton

Amy LacoutureBaton Rouge$663K
Amanda EymardHouma$617K
Amber LittlefieldBroussard$225K
Timothy PellegrinHouma$210K
Melissa GuilbeauLafayette$122K
Kimberly ForcinelShreveport$92K
Sattaria DilksLake Charles$57K
Joe TaylorHammond$38K
Lecy AlbaradoScott$34K
Michelle DyerLake Charles$33K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →